• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无症状阿尔茨海默病患者皮质下脑区铁含量增加的磁共振证据。

Magnetic resonance evidence of increased iron content in subcortical brain regions in asymptomatic Alzheimer's disease.

机构信息

Department of Neurology, School of Medicine, Emory University, Atlanta, Georgia, USA.

Department of Radiology and Imaging Sciences, School of Medicine, Emory University, Atlanta, Georgia, USA.

出版信息

Hum Brain Mapp. 2023 Jun 1;44(8):3072-3083. doi: 10.1002/hbm.26263. Epub 2023 Mar 16.

DOI:10.1002/hbm.26263
PMID:36929676
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10171513/
Abstract

While iron over-accumulation has been reported in late stage Alzheimer's disease (AD), whether this occurs early in the asymptomatic stage of AD remains unknown. We aimed to assess brain iron levels in asymptomatic AD using quantitative MR relaxometry of effective transverse relaxation rate (R2*) and longitudinal relaxation rate (R1), and recruited 118 participants comprised of three groups including healthy young participants, and cognitively normal older individuals without or with positive AD biomarkers based on cerebrospinal fluid (CSF) proteomics analysis. Compared with the healthy young group, increased R2* was found in widespread cortical and subcortical regions in the older groups. Further, significantly higher levels of R2* were found in the cognitively normal older subjects with positive CSF AD biomarker (i.e., asymptomatic AD) compared with those with negative AD biomarker in subcortical regions including the left and right caudate, left and right putamen, and left and right globus pallidus (p < .05 for all regions), suggesting increased iron content in these regions. Subcortical R2* of some regions was found to significantly correlate with CSF AD biomarkers and neuropsychological assessments of visuospatial functions. In conclusion, R2* could be a valuable biomarker for studying early pathophysiological changes in AD.

摘要

虽然铁过度积累已在晚期阿尔茨海默病(AD)中报道,但 AD 无症状阶段早期是否存在这种情况尚不清楚。我们旨在使用有效横向弛豫率(R2*)和纵向弛豫率(R1)的定量磁共振弛豫测量来评估无症状 AD 中的脑铁水平,并招募了 118 名参与者,包括健康的年轻参与者以及根据脑脊液(CSF)蛋白质组分析无认知障碍或有阳性 AD 生物标志物的认知正常老年人。与健康的年轻组相比,在老年组中广泛的皮质和皮质下区域发现 R2增加。此外,在认知正常的老年人中,CSF AD 生物标志物阳性(即无症状 AD)的 R2水平明显高于阴性 AD 生物标志物的老年人,在包括左和右尾状核、左和右壳核以及左和右苍白球在内的皮质下区域(所有区域的 p <.05),提示这些区域的铁含量增加。一些区域的皮质下 R2与 CSF AD 生物标志物和视觉空间功能的神经心理学评估显著相关。总之,R2可能是研究 AD 早期病理生理变化的有价值的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1fb/10171513/cd0aacef4fdc/HBM-44-3072-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1fb/10171513/ed16497207c3/HBM-44-3072-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1fb/10171513/a59d9be82f17/HBM-44-3072-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1fb/10171513/3683fcc52a5b/HBM-44-3072-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1fb/10171513/3f31fddd675b/HBM-44-3072-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1fb/10171513/cd0aacef4fdc/HBM-44-3072-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1fb/10171513/ed16497207c3/HBM-44-3072-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1fb/10171513/a59d9be82f17/HBM-44-3072-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1fb/10171513/3683fcc52a5b/HBM-44-3072-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1fb/10171513/3f31fddd675b/HBM-44-3072-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1fb/10171513/cd0aacef4fdc/HBM-44-3072-g005.jpg

相似文献

1
Magnetic resonance evidence of increased iron content in subcortical brain regions in asymptomatic Alzheimer's disease.无症状阿尔茨海默病患者皮质下脑区铁含量增加的磁共振证据。
Hum Brain Mapp. 2023 Jun 1;44(8):3072-3083. doi: 10.1002/hbm.26263. Epub 2023 Mar 16.
2
Association of Amyloid Pathology With Myelin Alteration in Preclinical Alzheimer Disease.阿尔茨海默病临床前期淀粉样蛋白病理与髓鞘改变的关联。
JAMA Neurol. 2017 Jan 1;74(1):41-49. doi: 10.1001/jamaneurol.2016.3232.
3
Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.与临床前阿尔茨海默病核心 CSF 生物标志物相关的纵向结构脑变化:两项独立数据集研究。
Neuroimage Clin. 2018 Apr 16;19:190-201. doi: 10.1016/j.nicl.2018.04.016. eCollection 2018.
4
Atrophy, metabolism and cognition in the posterior cortical atrophy spectrum based on Alzheimer's disease cerebrospinal fluid biomarkers.基于阿尔茨海默病脑脊液生物标志物的后部皮质萎缩谱中的萎缩、代谢和认知。
Neuroimage Clin. 2018;20:1018-1025. doi: 10.1016/j.nicl.2018.10.010. Epub 2018 Oct 10.
5
The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease.阿尔茨海默病患者脑脊液生物标志物与大脑结构变化的关系。
J Intern Med. 2014 Apr;275(4):418-27. doi: 10.1111/joim.12164. Epub 2013 Dec 11.
6
Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.从阿尔茨海默病临床前期到痴呆阶段的认知、脑萎缩和脑脊液生物标志物变化以及载脂蛋白E的影响
J Alzheimers Dis. 2015;45(1):253-68. doi: 10.3233/JAD-142451.
7
Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease.早期阿尔茨海默病中神经退行性变的脑脊液标志物与脑萎缩速度。
JAMA Neurol. 2015 Jun;72(6):656-65. doi: 10.1001/jamaneurol.2015.0202.
8
MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease.阿尔茨海默病和亨廷顿病中基底节铁蛋白铁及神经毒性的磁共振成像评估
Cell Mol Biol (Noisy-le-grand). 2000 Jun;46(4):821-33.
9
Investigation on positive correlation of increased brain iron deposition with cognitive impairment in Alzheimer disease by using quantitative MR R2' mapping.采用定量磁共振R2’ 图谱研究阿尔茨海默病脑铁沉积增加与认知障碍的正相关性。
J Huazhong Univ Sci Technolog Med Sci. 2011 Aug;31(4):578. doi: 10.1007/s11596-011-0493-1. Epub 2011 Aug 7.
10
Associations of Alcohol Consumption with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.认知正常的老年人饮酒与阿尔茨海默病病理的脑脊液生物标志物的相关性:CABLE 研究。
J Alzheimers Dis. 2021;82(3):1045-1054. doi: 10.3233/JAD-210140.

引用本文的文献

1
Imaging markers of neuroinflammation in aging and Alzheimer's disease and related dementia: A comprehensive review.衰老、阿尔茨海默病及相关痴呆症中神经炎症的影像学标志物:综述
Neurosci Biobehav Rev. 2025 Jun 25;176:106270. doi: 10.1016/j.neubiorev.2025.106270.
2
Change in transverse relaxation rates (R) and change in cognition for older African Americans.老年非裔美国人横向弛豫率(R)的变化与认知变化
Hum Brain Mapp. 2025 Jan;46(1):e26794. doi: 10.1002/hbm.26794.
3
Evaluation of iron deposition in diabetic kidney disease using the kidney-to-muscle signal intensity ratio on routine MRI T2WI sequences.

本文引用的文献

1
Model-based multi-parameter mapping.基于模型的多参数映射。
Med Image Anal. 2021 Oct;73:102149. doi: 10.1016/j.media.2021.102149. Epub 2021 Jun 29.
2
Investigation of the association between cerebral iron content and myelin content in normative aging using quantitative magnetic resonance neuroimaging.采用定量磁共振神经影像学技术研究正常老化过程中脑铁含量与髓鞘含量的相关性。
Neuroimage. 2021 Oct 1;239:118267. doi: 10.1016/j.neuroimage.2021.118267. Epub 2021 Jun 15.
3
Microglia in Aging and Alzheimer's Disease: A Comparative Species Review.
利用常规MRI T2WI序列上的肾肌信号强度比评估糖尿病肾病中的铁沉积。
Abdom Radiol (NY). 2025 Feb 10. doi: 10.1007/s00261-025-04827-w.
4
Accelerated model-based T1, T2* and proton density mapping using a Bayesian approach with automatic hyperparameter estimation.基于贝叶斯方法的加速模型 T1、T2* 和质子密度图绘制,具有自动超参数估计功能。
Magn Reson Med. 2025 Feb;93(2):563-583. doi: 10.1002/mrm.30295. Epub 2024 Sep 13.
5
Ferroptosis in Cognitive Impairment Associated with Diabetes and Alzheimer's Disease: Mechanistic Insights and New Therapeutic Opportunities.与糖尿病和阿尔茨海默病相关的认知障碍中的铁死亡:机制见解与新的治疗机会
Mol Neurobiol. 2025 Feb;62(2):2435-2449. doi: 10.1007/s12035-024-04417-9. Epub 2024 Aug 7.
6
Do toenail manganese and iron levels reflect brain metal levels or brain metabolism in welders?电焊工的趾甲锰和铁水平是否反映大脑中的金属水平或大脑代谢?
Neurotoxicology. 2024 Sep;104:45-55. doi: 10.1016/j.neuro.2024.07.007. Epub 2024 Jul 11.
7
Exploring Potential Mechanisms Accounting for Iron Accumulation in the Central Nervous System of Patients with Alzheimer's Disease.探索导致阿尔茨海默病患者中枢神经系统铁积累的潜在机制。
Cells. 2024 Apr 16;13(8):689. doi: 10.3390/cells13080689.
8
R-Mixup: Riemannian Mixup for Biological Networks.R-Mixup:生物网络的黎曼混合
KDD. 2023 Aug;2023:1073-1085. doi: 10.1145/3580305.3599483. Epub 2023 Aug 4.
9
Examining the Role of a Functional Deficiency of Iron in Lysosomal Storage Disorders with Translational Relevance to Alzheimer's Disease.探讨铁功能缺陷在溶酶体贮积症中的作用及其对阿尔茨海默病的转化相关性。
Cells. 2023 Nov 16;12(22):2641. doi: 10.3390/cells12222641.
10
Iron chelators as a therapeutic option for Alzheimer's disease-A mini-review.铁螯合剂作为阿尔茨海默病的一种治疗选择——一篇综述
Front Aging. 2023 Aug 2;4:1234958. doi: 10.3389/fragi.2023.1234958. eCollection 2023.
衰老和阿尔茨海默病中的小胶质细胞:比较物种综述。
Cells. 2021 May 8;10(5):1138. doi: 10.3390/cells10051138.
4
Age-related differences in myeloarchitecture measured at 7 T.7T 测量的骨髓结构与年龄相关的差异。
Neurobiol Aging. 2020 Dec;96:246-254. doi: 10.1016/j.neurobiolaging.2020.08.009. Epub 2020 Aug 22.
5
Cross-sectional and Longitudinal Assessment of Brain Iron Level in Alzheimer Disease Using 3-T MRI.使用 3T MRI 对阿尔茨海默病患者脑内铁水平进行横断面和纵向评估。
Radiology. 2020 Sep;296(3):619-626. doi: 10.1148/radiol.2020192541. Epub 2020 Jun 30.
6
Relationship between cortical iron and tau aggregation in Alzheimer's disease.阿尔茨海默病患者皮质铁与tau 聚集的关系。
Brain. 2020 May 1;143(5):1341-1349. doi: 10.1093/brain/awaa089.
7
Rationale and Design of the Emory Healthy Aging and Emory Healthy Brain Studies.埃默里健康老龄化和埃默里健康大脑研究的原理和设计。
Neuroepidemiology. 2019;53(3-4):187-200. doi: 10.1159/000501856. Epub 2019 Aug 27.
8
Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology.脑铁与阿尔茨海默病患者认知能力加速下降有关。
Mol Psychiatry. 2020 Nov;25(11):2932-2941. doi: 10.1038/s41380-019-0375-7. Epub 2019 Feb 18.
9
Brain Iron Homeostasis: A Focus on Microglial Iron.脑铁稳态:聚焦小胶质细胞铁
Pharmaceuticals (Basel). 2018 Nov 23;11(4):129. doi: 10.3390/ph11040129.
10
Postmortem T2*- Weighted MRI Imaging of Cortical Iron Reflects Severity of Alzheimer's Disease.死后 T2*-加权 MRI 成像皮质铁反映阿尔茨海默病的严重程度。
J Alzheimers Dis. 2018;65(4):1125-1137. doi: 10.3233/JAD-180317.